14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TBPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Theravance Biopharma stock upgraded to Buy Candidate.
(Updated on May 01, 2024)

Buy candidate since May 01, 2024 PDF

The Theravance Biopharma stock price gained 4.74% on the last trading day (Wednesday, 1st May 2024), rising from $8.44 to $8.84. During the last trading day the stock fluctuated 6.90% from a day low at $8.40 to a day high of $8.98. The price has fallen in 7 of the last 10 days and is down by -7.14% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $18.11 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 6.59% during the next 3 months and, with a 90% probability hold a price between $9.01 and $10.70 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TBPH Signals & Forecast

The Theravance Biopharma stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.99 and $9.11. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Some positive signals were issued as well, and these may have some influence on the near short-term development. A buy signal was issued from a pivot bottom point on Tuesday, April 30, 2024, and so far it has risen 4.74%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Theravance Biopharma stock

Theravance Biopharma finds support from accumulated volume at $8.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.580 between high and low, or 6.90%. For the last week, the stock has had daily average volatility of 4.49%.

Our recommended stop-loss: $8.47 (-4.22%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (TBPH) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Theravance Biopharma to open at $8.74, and during the day (based on 14 day Average True Range), to move between $8.45 and $9.23, which gives a possible trading interval of +/-$0.393 (+/-4.45%) up or down from last closing price. If Theravance Biopharma takes out the full calculated possible swing range there will be an estimated 8.90% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.85 (0.11%) than the support at $8.80 (0.45%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Theravance Biopharma stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.059 Buy Candidate Upgraded

Predicted Opening Price for Theravance Biopharma of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$8.74 ( 1.13%) $8.84

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TBPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.32 5.43 %
R2 9.10 2.92 %
R1 8.96 1.38 %
Current price: 8.84
Support S1 8.52 -3.64 %
S2 8.38 -5.19 %
S3 8.16 -7.69 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.69 9.62 %
R2 9.10 2.94 %
R1 8.85 0.113 %
Current price 8.84
Support S1 8.80 -0.452%
S2 8.64 -2.26%
S3 8.22 -7.01%

FAQ

What is the symbol for Theravance Biopharma Stock and on which exchange is it traded?
The symbol for Theravance Biopharma is TBPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Theravance Biopharma Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy Theravance Biopharma Stock?
Theravance Biopharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Theravance Biopharma Stock.

What's the current price of Theravance Biopharma Stock?
As of the end of day on the May 01, 2024, the price of an Theravance Biopharma (TBPH) share was $8.84.

What is the 52-week high and low for Theravance Biopharma Stock?
The 52-week high for Theravance Biopharma Stock is $11.98 and the 52-week low is $8.22.

What is the market capitalization of Theravance Biopharma Stock?
As of the May 01, 2024, the market capitalization of Theravance Biopharma is 425.776M.

When is the next earnings date for Theravance Biopharma?
The upcoming earnings date for Theravance Biopharma is May 13, 2024.
Click to get the best stock tips daily for free!

About Theravance Biopharma

Theravance Biopharma Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical tr... TBPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT